| Literature DB >> 30413168 |
Donna Allen1, Erica Wandtke Hines2, Vanessa Pazdernik3, Lynda Tierney Konecny3, Erin Breitenbach3.
Abstract
BACKGROUND: Historically, in an effort to evaluate and manage the rising cost of healthcare employers assess the direct cost burden via medical health claims and measures that yield clear data. Health related indirect costs are harder to measure and are often left out of the comprehensive overview of health expenses to an employer. Presenteeism, which is commonly referred to as an employee at work who has impaired productivity due to health considerations, has been identified as an indirect but relevant factor influencing productivity and human capitol. The current study evaluated presenteeism among employees of a large United States health care system that operates in six locations over a four-year period and estimated loss productivity due to poor health and its potential economic burden.Entities:
Keywords: Depression; Employees; Headaches; Health; Health care system; Human resources; Mental illness; Presenteeism; Productivity loss; Workplace wellness
Mesh:
Year: 2018 PMID: 30413168 PMCID: PMC6234777 DOI: 10.1186/s12960-018-0321-9
Source DB: PubMed Journal: Hum Resour Health ISSN: 1478-4491
Assignment of productivity loss time categories
| Time category | Midpoint |
|---|---|
| None of the time | 0 |
| A little of the time | 30 |
| Some of the time | 119.5 |
| A lot of the time | 239.5 |
| Most of the time | 359.5 |
| All of the time | 450 |
Internal consistency of minutes of productivity loss for the four productivity areas by medical condition
| Medical condition | Cronbach |
|---|---|
| Any allergies (including seasonal) | 0.73 (0.71–0.75) |
| Any cancer | 0.78 (0.69–0.88) |
| Arthritis | 0.65 (0.61–0.68) |
| Asthma | 0.84 (0.81–0.90) |
| Autoimmune disease | 0.88 (0.86–0.91) |
| Cerebrovascular disease/strokea | 0.64 (0.51–0.77) |
| Chronic back pain | 0.77 (0.73–0.81) |
| Depression | 0.85 (0.80–0.89) |
| Digestive disorder | 0.82 (0.75–0.85) |
| General anxiety | 0.84 (0.82–0.85) |
| Heart disease | 0.69 (0.38–0.84) |
| Hypertension (high blood pressure) | 0.77 (0.62–0.85) |
| Mental illness | 0.85 (0.80–0.88) |
| Migraines or severe headaches | 0.87 (0.85–0.89) |
| Neck pain | 0.74 (0.67–0.85) |
| Other metabolic disease (thyroid, kidney/renal, liver) | 0.87 (0.80–0.93) |
| Peripheral vascular diseaseb | 0.78 (0.67–0.99) |
| Pulmonary disease | 0.62 (0.33–0.82) |
| Respiratory (chronic bronchitis, emphysema, or sinusitis) | 0.90 (0.82–0.96) |
| Seizure disorders | 0.91 (0.88–0.94) |
| Type I diabetes | 0.71 (0.20–0.92) |
| Type II diabetes | 0.87 (0.82–0.91) |
Data are presented as mean (minimum to maximum) for the four yearly periods
aCronbach α was not estimable for all four periods because there was no variation in minutes for at least one of the productivity areas. Only two periods were assessed for this condition
bCronbach α was not estimable for all four periods because there was no variation in minutes for at least one of the productivity areas. Only three periods were assessed for this condition
Mean health-related productivity loss instrument outcomes for presenteeism across the four yearly periods
| Medical condition | Affected, No. (%) | Estimated daily productivity loss per person, mina | Estimated annual cost per person, $a | Estimated annual company cost, $a |
|---|---|---|---|---|
| Chronic back pain | 631 (4.3) | 16.7 (0.84) | 1 920 (98) | 1 210 000 (62 000) |
| Mental illness | 44 (0.3) | 16.6 (3.28) | 2 100 (480) | 94 000 (21 000) |
| General anxiety | 743 (5.1) | 16.2 (0.75) | 1 920 (93) | 1 430 000 (69 000) |
| Migraines or severe headaches | 1 192 (8.2) | 14.7 (0.60) | 1 690 (70) | 2 020 000 (83 000) |
| Neck pain | 477 (3.3) | 11.2 (0.68) | 1 290 (80) | 610 000 (38 000) |
| Depression | 862 (5.9) | 9.9 (0.57) | 1 150 (66) | 990 000 (57 000) |
| Autoimmune disease | 283 (1.9) | 9.5 (1.14) | 1 090 (130) | 310 000 (37 000) |
| Arthritis | 1 124 (7.7) | 8.2 (0.42) | 930 (48) | 1 040 000 (54 000) |
| Type I diabetes | 78 (0.5) | 6.5 (1.54) | 710 (170) | 56 000 (13 000) |
| Any allergies (including seasonal) | 4 026 (27.6) | 6.2 (0.19) | 716 (23) | 2 880 000 (92 000) |
| Respiratory (chronic bronchitis, emphysema, or sinusitis) | 186 (1.3) | 5.4 (0.88) | 630 (106) | 117 000 (20 000) |
| Digestive disorder | 543 (3.7) | 5.3 (0.47) | 600 (54) | 327 000 (30 000) |
| Pulmonary disease | 21 (0.1) | 4.1 (1.57) | 450 (170) | 10 000 (3 600) |
| Any cancer | 285 (2.0) | 3.4 (0.61) | 410 (75) | 118 000 (21 000) |
| Asthma | 1 017 (7.0) | 3.1 (0.26) | 350 (30) | 350 000 (31 000) |
| Type II diabetes | 887 (6.1) | 2.4 (0.29) | 270 (33) | 244 000 (29 000) |
| Seizure disorders | 59 (0.4) | 2.0 (0.87) | 240 (103) | 14 000 (6 000) |
| Heart disease | 323 (2.2) | 2.0 (0.36) | 230 (42) | 75 000 (14 000) |
| Other metabolic disease (thyroid, kidney/renal, liver) | 948 (6.5) | 1.6 (0.20) | 179 (23) | 169 000 (22 000) |
| Hypertension (high blood pressure) | 3 208 (22.0) | 1.1 (0.09) | 126 (10) | 400 000 (33 000) |
| Peripheral vascular disease | 38 (0.3) | 0.9 (0.41) | 90 (48) | 3 600 (1 800) |
| Cerebrovascular disease/stroke | 34 (0.2) | 0.8 (0.36) | 90 (38) | 2 900 (1 300) |
Data are presented in descending order of mean minutes of estimated daily productivity loss per person
aData are reported with associated standard error
Fig. 1Daily Productivity Loss Per Person (min) from Presenteeism by Period. *Tukey adjustment P <.05
Fig. 2Annual Cost Per Person ($) from Presenteeism by Period. *Tukey adjustment P <.05
Consistency of reported productivity loss from presenteeism across the four periods by medical condition
| Medical condition | |||||
|---|---|---|---|---|---|
| No. | Overall | Unaffected, 0 min | Affected, 0 min | Affected, > 0 min | |
| Type II diabetes | 22 893 | 0.81 | 0.85 | 0.80 | 0.36 |
| Hypertension (high blood pressure) | 22 892 | 0.77 | 0.80 | 0.78 | 0.23 |
| Asthma | 22 893 | 0.74 | 0.80 | 0.72 | 0.36 |
| Seizure disorders | 22 893 | 0.73 | 0.76 | 0.72 | 0.38 |
| Type I diabetes | 22 893 | 0.69 | 0.78 | 0.64 | 0.50 |
| Heart disease | 22 892 | 0.61 | 0.64 | 0.61 | 0.29 |
| Other metabolic disease (thyroid, kidney/renal, liver) | 22 892 | 0.60 | 0.63 | 0.60 | 0.26 |
| Autoimmune disease | 22 891 | 0.58 | 0.66 | 0.55 | 0.40 |
| Depression | 22 893 | 0.54 | 0.62 | 0.51 | 0.35 |
| Migraines or severe headaches | 22 889 | 0.54 | 0.64 | 0.47 | 0.42 |
| Mental illness | 22 893 | 0.53 | 0.58 | 0.51 | 0.43 |
| Arthritis | 22 892 | 0.51 | 0.59 | 0.47 | 0.32 |
| Any cancer | 22 887 | 0.49 | 0.52 | 0.50 | 0.08 |
| Cerebrovascular disease/stroke | 22 892 | 0.46 | 0.47 | 0.48 | 0.12 |
| Any allergies (including seasonal) | 22 890 | 0.44 | 0.51 | 0.40 | 0.28 |
| Pulmonary disease | 22 893 | 0.44 | 0.47 | 0.46 | 0.11 |
| General anxiety | 22 893 | 0.42 | 0.49 | 0.37 | 0.33 |
| Chronic back pain | 22 891 | 0.40 | 0.48 | 0.33 | 0.32 |
| Digestive disorder | 22 892 | 0.39 | 0.43 | 0.36 | 0.32 |
| Peripheral vascular disease | 22 893 | 0.34 | 0.38 | 0.31 | 0.20 |
| Neck pain | 22 890 | 0.32 | 0.39 | 0.28 | 0.23 |
| Respiratory (chronic bronchitis, emphysema, or sinusitis) | 22 893 | 0.28 | 0.31 | 0.26 | 0.20 |
Data are presented in descending order of overall κ